Net Income (Loss) Attributable to Parent in USD of OCULAR THERAPEUTIX, INC from 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
OCULAR THERAPEUTIX, INC quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from 2012 to Q3 2025.
  • OCULAR THERAPEUTIX, INC Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$69.4M, a 90.2% decline year-over-year.
  • OCULAR THERAPEUTIX, INC Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$250M, a 43.2% decline year-over-year.
  • OCULAR THERAPEUTIX, INC annual Net Income (Loss) Attributable to Parent for 2024 was -$194M, a 140% decline from 2023.
  • OCULAR THERAPEUTIX, INC annual Net Income (Loss) Attributable to Parent for 2023 was -$80.7M, a 13.7% decline from 2022.
  • OCULAR THERAPEUTIX, INC annual Net Income (Loss) Attributable to Parent for 2022 was -$71M, a 984% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

OCULAR THERAPEUTIX, INC Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$250M -$69.4M -$32.9M -90.2% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 -$217M -$67.8M -$24M -54.9% 01 Apr 2025 30 Jun 2025 10-Q 04 Nov 2025
Q1 2025 -$193M -$64.1M +$795K +1.23% 01 Jan 2025 31 Mar 2025 10-Q 04 Nov 2025
Q4 2024 -$194M -$48.4M -$19.2M -65.6% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2025
Q3 2024 -$174M -$36.5M -$36M -6972% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 -$138M -$43.8M -$23.1M -112% 01 Apr 2024 30 Jun 2024 10-Q 04 Nov 2025
Q1 2024 -$115M -$64.8M -$34.5M -114% 01 Jan 2024 31 Mar 2024 10-Q 04 Nov 2025
Q4 2023 -$80.7M -$29.2M -$13.7M -88% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2025
Q3 2023 -$67.1M -$516K +$23.7M +97.9% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$90.7M -$20.7M -$1.92M -10.2% 01 Apr 2023 30 Jun 2023 10-Q 14 Nov 2024
Q1 2023 -$88.8M -$30.3M -$17.8M -142% 01 Jan 2023 31 Mar 2023 10-Q 14 Nov 2024
Q4 2022 -$71M -$15.5M -$11.7M -304% 01 Oct 2022 31 Dec 2022 10-K 03 Mar 2025
Q3 2022 -$59.3M -$24.2M -$26.8M -1010% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$32.5M -$18.8M -$10.3M -121% 01 Apr 2022 30 Jun 2022 10-Q 07 Nov 2023
Q1 2022 -$22.2M -$12.5M -$15.7M -502% 01 Jan 2022 31 Mar 2022 10-Q 07 Nov 2023
Q4 2021 -$6.55M -$3.85M +$81.8M +95.5% 01 Oct 2021 31 Dec 2021 10-K 11 Mar 2024
Q3 2021 -$88.3M $2.66M +$14.6M 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 -$103M -$8.48M +$28.1M +76.8% 01 Apr 2021 30 Jun 2021 10-Q 07 Nov 2022
Q1 2021 -$131M $3.12M +$24.6M 01 Jan 2021 31 Mar 2021 10-Q 07 Nov 2022
Q4 2020 -$156M -$85.6M -$59.6M -229% 01 Oct 2020 31 Dec 2020 10-K 06 Mar 2023
Q3 2020 -$96M -$11.9M +$6.83M +36.4% 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021
Q2 2020 -$103M -$36.6M -$12.1M -49.5% 01 Apr 2020 30 Jun 2020 10-Q 08 Nov 2021
Q1 2020 -$90.8M -$21.5M -$4.39M -25.6% 01 Jan 2020 31 Mar 2020 10-Q 08 Nov 2021
Q4 2019 -$86.4M -$26M -$8.62M -49.5% 01 Oct 2019 31 Dec 2019 10-K 12 Mar 2020
Q3 2019 -$77.8M -$18.8M -$3.77M -25.1% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 -$74M -$24.5M -$10.6M -77.1% 01 Apr 2019 30 Jun 2019 10-Q 05 Nov 2020
Q1 2019 -$63.3M -$17.1M -$3.36M -24.4% 01 Jan 2019 31 Mar 2019 10-Q 05 Nov 2020
Q4 2018 -$60M -$17.4M -$4.3M -32.8% 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020
Q3 2018 -$55.7M -$15M +$557K +3.58% 01 Jul 2018 30 Sep 2018 10-K 12 Mar 2020
Q2 2018 -$56.2M -$13.8M +$4.89M +26.2% 01 Apr 2018 30 Jun 2018 10-K 12 Mar 2020
Q1 2018 -$61.1M -$13.8M +$2.26M +14.1% 01 Jan 2018 31 Mar 2018 10-K 12 Mar 2020
Q4 2017 -$63.4M -$13.1M -$280K -2.18% 01 Oct 2017 31 Dec 2017 10-K 07 Mar 2019
Q3 2017 -$63.1M -$15.6M -$5.97M -62.2% 01 Jul 2017 30 Sep 2017 10-K 07 Mar 2019
Q2 2017 -$57.1M -$18.7M -$7.25M -63.3% 01 Apr 2017 30 Jun 2017 10-K 07 Mar 2019
Q1 2017 -$49.9M -$16M -$5.18M -47.8% 01 Jan 2017 31 Mar 2017 10-K 07 Mar 2019
Q4 2016 -$44.7M -$12.8M -$2.19M -20.5% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 -$42.5M -$9.6M +$1.93M +16.7% 01 Jul 2016 30 Sep 2016 10-K 08 Mar 2018
Q2 2016 -$44.4M -$11.4M -$1.44M -14.3% 01 Apr 2016 30 Jun 2016 10-K 08 Mar 2018
Q1 2016 -$43M -$10.8M -$3.26M -43% 01 Jan 2016 31 Mar 2016 10-K 08 Mar 2018
Q4 2015 -$39.7M -$10.6M -$2.68M -33.7% 01 Oct 2015 31 Dec 2015 10-K 10 Mar 2017
Q3 2015 -$37.1M -$11.5M -$4.23M -58% 01 Jul 2015 30 Sep 2015 10-K 10 Mar 2017
Q2 2015 -$32.8M -$10M -$3.62M -56.6% 01 Apr 2015 30 Jun 2015 10-K 10 Mar 2017
Q1 2015 -$29.2M -$7.58M -$570K -8.13% 01 Jan 2015 31 Mar 2015 10-K 10 Mar 2017
Q4 2014 -$28.6M -$7.95M -$4.45M -127% 01 Oct 2014 31 Dec 2014 10-K 10 Mar 2016
Q3 2014 -$24.2M -$7.29M -$3.77M -107% 01 Jul 2014 30 Sep 2014 10-K 10 Mar 2016
Q2 2014 -$20.4M -$6.39M -$3.3M -107% 01 Apr 2014 30 Jun 2014 10-K 10 Mar 2016
Q1 2014 -$17.1M -$7.01M -$3.81M -119% 01 Jan 2014 31 Mar 2014 10-K 10 Mar 2016
Q4 2013 -$13.3M -$3.51M 01 Oct 2013 31 Dec 2013 10-K 20 Mar 2015
Q3 2013 -$3.52M 01 Jul 2013 30 Sep 2013 10-K 20 Mar 2015
Q2 2013 -$3.09M 01 Apr 2013 30 Jun 2013 10-K 20 Mar 2015
Q1 2013 -$3.2M 01 Jan 2013 31 Mar 2013 10-K 20 Mar 2015

OCULAR THERAPEUTIX, INC Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$194M -$113M -140% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2025
2023 -$80.7M -$9.7M -13.7% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2025
2022 -$71M -$64.5M -984% 01 Jan 2022 31 Dec 2022 10-K 03 Mar 2025
2021 -$6.55M +$149M +95.8% 01 Jan 2021 31 Dec 2021 10-K 11 Mar 2024
2020 -$156M -$69.3M -80.2% 01 Jan 2020 31 Dec 2020 10-K 06 Mar 2023
2019 -$86.4M -$26.4M -44% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 -$60M +$3.41M +5.38% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020
2017 -$63.4M -$18.7M -41.8% 01 Jan 2017 31 Dec 2017 10-K 12 Mar 2020
2016 -$44.7M -$4.96M -12.5% 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2019
2015 -$39.7M -$11.1M -38.7% 01 Jan 2015 31 Dec 2015 10-K 08 Mar 2018
2014 -$28.6M -$15.3M -115% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017
2013 -$13.3M +$776K +5.51% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016
2012 -$14.1M 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.